4BIO Ventures III Overview
4BIO Ventures III General Information
Description
4BIO Ventures III is an early-stage venture capital fund managed by 4BIO Capital. The fund is located in London, United Kingdom.
Contact Information
Fund Manager's Location
- 20 North Audley Street
- London W1K 6WE
- England, United Kingdom
4BIO Ventures III Investments (7)
4BIO Ventures III has made a total of 7 investments. Its most recent deal was a with Trogenix for . The deal was made on 06-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Trogenix | 06-Oct-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Actithera | 09-Jul-2025 | Drug Discovery | Pre-Clinical Trials | |||
| NV Therapeutics | 13-Mar-2025 | Biotechnology | Startup | |||
| March Biosciences | 03-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Cytospire | 01-Oct-2024 | Biotechnology | Pre-Clinical Trials | |||
| Trogenix | 16-Aug-2024 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| ViaNautis | 06-Jul-2023 | Later Stage VC (Series A) | Drug Delivery | Generating Revenue |
4BIO Ventures III Investment Strategy
Investments by Industry
Investments by Deal Type
4BIO Ventures III Limited Partners (10)
Children's Minnesota is one of 4BIO Ventures III’s 10 limited partners. Its latest Original was on 22-Mar-2025.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Children's Minnesota | Current | 22-Mar-2025 | Original | ||
| Kyowa Kirin | Current | 22-Mar-2025 | Original | ||
| Organization for Small & Medium Enterprises and Regional Innovation | Current | 22-Mar-2025 | Original | ||
| University of Pittsburgh Medical Center | 22-Mar-2025 | Original | |||
| Yale-New Haven Hospital | Foundation | Current | 22-Mar-2025 | Original |
4BIO Ventures III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
4BIO Ventures III Benchmark (73)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Transition Global I | 30-Jun-2026 | ||||
| Middlegame Ventures Seed Fund I | |||||
| BNVT Capital Fund | |||||
| Hummingbird Ventures V | |||||
| SCV Fund II | |||||
| Moonfire Ventures Fund II | |||||
| Moonfire Ventures Opportunity Fund I | |||||
| Blockraise I | |||||
| Impact Ireland USA | |||||
| Female Founders Fund F |
4BIO Ventures III FAQs
-
What is 4BIO Ventures III?
4BIO Ventures III is an early-stage venture capital fund managed by 4BIO Capital.
-
Who manages 4BIO Ventures III?
4BIO Ventures III is managed by 4BIO Capital.
-
Where is 4BIO Ventures III domiciled?
4BIO Ventures III is domiciled in United Kingdom.
-
What is 4BIO Ventures III's size?
4BIO Ventures III has a size of .
-
What type of fund is 4BIO Ventures III?
The fund type of 4BIO Ventures III is Venture.
-
What is the status of 4BIO Ventures III?
4BIO Ventures III is closed.
-
What has 4BIO Ventures III invested in?
4BIO Ventures III has made numerous investments in companies like Trogenix, Actithera, and NV Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has 4BIO Ventures III invested in recently?
4BIO Ventures III's latest investment was on 06-Oct-2025 in Trogenix, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
